1. Ashkenazi R, Finberg JPM, Youdim MBH (1983) Effect of LM5008, a selective inhibitor of 5-hydroxy-tryptamine uptake, in blood pressure and responses to sympathomimetic amines. Br J Pharmacol 79: 915–922.
2. Brown DL, Guyenet PG (1984) Cardiovascular neurons of brain stem with projections to the spinal cord. Am J Physiol 247: R1009–1016.
3. Coote JH, Dalton DW, Feniuk FW, Humphrey PP (1987) The central site of sympathoinhibitory action of 5-hydroxy tryptamine in the cat. Neuropharmacology 26: 147–154.
4. Da Prada M, Kettler R, Burkard WP, Haefely WE (1984) Moclobemide, an antidepressant with short-acting MAO-A inhibition: brain catecholamines and tyramine pressor effects in rats. In: Tipton KF, Dosiert P, Strolin-Benedetti M (eds) Monoamine oxidase and disease. Prospect for therapy with reversible inhibitors. Academic Press, London, pp 137–154.
5. Da Prada M, Kettler R, Keller HH, Burkard WP, Muggli-Maniglio D, Haefely WE (1989) Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A. J Pharmacol Exp Ther 248: 400–414.